Technology Advances Anticounterfeiting Options

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.

Vitrakvi (larotrectinib) was first granted accelerated approval by FDA in November 2018.